Pharmacokinetics of panomifene in healthy volunteers at phase I/a study

Anti-Cancer Drugs

Volumn 8, Issue 6, 1997, Pages 603-609

  Erdélyi Tóth, Valéria ^a   Gyergyay, Fruzsina ^a   Számel, Iréne ^a   Pap, Éva ^a   Kralovánszky, Judit ^a   Bojti, Erzsébet ^b   Csörgö, Margit ^b   Drabant, Sándor ^b   Klebovich, Imre ^b  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b EGIS PHARMACEUTICALS LTD   (Hungary)

Author keywords

Antiestrogen; Panomifene; Pharmacokinetics; Phase I a study; Tamoxifen analog

Indexed keywords

PANOMIFENE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL;

DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; MIDDLE AGED; MODELS, BIOLOGICAL; POSTMENOPAUSE; REGRESSION ANALYSIS; TAMOXIFEN;

EID: 0030867810     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199707000-00008     Document Type: Article

References (17)

1. Tory K, Csányi E, Horvath T, et al. GYKI-13504, a new antiestrogen with antitumour properties. In: Eckhardt S, Kerpel-Fronius S, eds. CMEA Chemotherapy Symposium 1984. Budapest: Akadémiai Kiadó 1985: 509-15.
2. Vincze B, Csuka O, Fekete M, et al. The interaction of EGIS-5650 a new potent antiestrogen with estrogen receptor of MCF-7 human breast cancer cells. Hormones and Breast Cancer, From biology to the clinic. Satellite of the Ninth International Congress of Endocrinology, Nice, 1992 (abstr).
3. Gyergyay F, Erdélyi-Tóth V, Számel I, et al. Phase I/a study of Panomifene in healthy volunteers. Ann Oncol 1992; 3: 54.
4. Számel I, Budai B, Gyergyay F, et al. Endocrine effects of panomifene (EGIS-5650) on healthy volunteers: a phase I/a study (in Hungarian). Orvosi Hetilap 1994; 135: 1077-81.
5. Számel I, Budai B, Gyergyay F, et al. Endocrine effects of EGIS-5650 (Panomifene) on healthy volunteers: a phase I/a study. In: Jonat W, Kaufman M, Munk M (eds): Hormone-dependent tumors. Basic research and clinical studies. Basel: Karger 1995: 210-20.
6. Erdélyi-Tóth V, Pap E, Kralovánszky J, et al. Determination of panomifene in human plasma by high performance liquid chromatography. J Chromatogr A 1994; 668: 419-25.
7. Ottaway JH. Normalization in the fitting of data by iterative methods: application to tracer kinetics and enzyme kinetics. Biochem J 1973; 134: 729-36.
8. Tallarida RJ, Murray RB. Manual of pharmacologic calculations with computer programs. New York: Springer-Verlag 1986: 134-7.
9. Adam HK, Patterson JS, Kemp JV. Studies on the metabolism and pharmacokinetics of tamoxifen in normal volunteers. Cancer Treat Rep 1980; 64: 761-4.
10. Nieder M, Jaeger H. Quantification of tamoxifen and N-des-methyltamoxifen in human plasma by high-performance liquid chromatography, photochemical reaction and fluorescence detection and its application to biopharmaceutic investigations. J Chromatogr 1987; 413: 207-17.
11. Tukker JJ, Blankenstein MA, Nortier JW. Comparison of bioavailability in man of tamoxifen after oral and rectal administration. J Pharm Pharmacol 1986; 38: 888-92.
12. Lien EA, Ueland PM, Solheim E, et al. Determination of tamoxifen and four metabolites in serum by low-dispersion liquid chromatography. Clin Chem 1987; 33: 1608-14.
13. Wiebe VJ, Benz CC, Shemano I, et al. Pharmacokinetics of toremifene and its metabolites in patients with advanced breast cancer. Cancer Chemother Pharmacol 1990; 25: 247-51.
14. Grill HJ, Pollow K. Pharmacokinetics of droloxifene and its metabolites in breast cancer patients. Am J Clin Oncol 1991; 14 (suppl 2): 21-9.
15. Wilkinson P, Ribeiro G, Adam HK, et al. Clinical pharmacology of tamoxifen and N-desmethyltamoxifen in patients with advanced breast cancer. Cancer Chemother Pharmacol 1980; 5: 109-11.
16. Fabian C, Sternson L, Barnett M. Clinical pharmacology of tamoxifen in patient with breast cancer: comparison of traditional and loading dose schedule. Cancer Treat Rep 1980; 64: 765-73.
17. Etienne MC, Milano G, Fischel JL, et al. Tamoxifen metabolism: pharmacokinetic and in vitro study. Br J Cancer 1989; 60: 30-5.